EntryPoint Capital’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-73,293
| Closed | -$202K | – | 815 |
|
|
2025
Q1 | $202K | Buy |
73,293
+12,905
| +21% | +$35.6K | 0.09% | 534 |
|
|
2024
Q4 | $335K | Buy |
+60,388
| New | +$335K | 0.14% | 305 |
|
|
2024
Q3 | – | Sell |
-9,069
| Closed | -$61.8K | – | 1119 |
|
|
2024
Q2 | $61.8K | Sell |
9,069
-4,301
| -32% | -$29.3K | 0.09% | 486 |
|
|
2024
Q1 | $87.7K | Sell |
13,370
-14,915
| -53% | -$97.8K | 0.08% | 496 |
|
|
2023
Q4 | $184K | Buy |
+28,285
| New | +$184K | 0.18% | 114 |
|